References
- Berg W., Korsan-Bengtsen K., Ygge J. Preparation of human plasminogen suitable as substrate for quantitative determination of plasminogen activators. Thrombos. Diathes. haemorrh. Stuttg. 1966; 15: 511
- Jacobsen C. D. The caseinolytic method for determination of plasminogen-plasmin in human plasma and serum. Scand. J. clin. Lab. Invest. 1964; 16: 372
- Jacobsen C. D. The antiplasmin activity of human plasma and serum and its dependence on ions. Scand. J. clin. Lab. Invest. 1964; 16: 383
- Jacobsen C. D., Chandler A. B. Thrombolysis in vitro I. Method, comparison of various thrombolytic agents and factors influencing thrombolysis. Scand. J. clin. Lab. Invest. 1965; 17: 209, Suppl. 84
- Jacobsen C. D. A family with low proteolytic capacity in plasma, probably related to a low plasminogen content. Scand. J. clin. Invest. 1966; 18: 359
- Jacobsen C. D. Proteolytic capacity in plasma. I. Measurement of proteolytic activity in the presence of natural inhibitors and study of the individual variations, In press
- von Kaulla K. N. Fibrinolysis induction in vitro by aromatic derivatives. Arch. Biochem. 1962; 96: 4
- von Kaulla K. N. Chemical structure and fibrinolysis induction. In vitro studies with 126 synthetic compounds. Thrombos. Diathes. haemorrh. Stuttg. 1962; 7: 404
- von Kaulla K. N. Inactivation of antiplasmin and complement C1in human plasma rendered fibrinolytic by synthetic organic compounds. Thrombos. Diathes. haemorrh. Stuttg. 1963; 10: 151
- von Kaulla K. N. Synthetic activators of fibrinolysis which possess anticoagulant property. Experientia 1965; 21: 439
- von Kaulla K. N. Animal plasma as substrate for synthetic fibrinolysis inducers. Proc. Soc. exp. Biol. N.Y. 1966; 121: 46